ClearPoint Neuro Inc.

NASDAQ: CLPT · Real-Time Price · USD
12.97
0.31 (2.45%)
At close: Jun 04, 2025, 3:59 PM
13.24
2.08%
After-hours: Jun 04, 2025, 05:44 PM EDT

ClearPoint Neuro Statistics

Share Statistics

ClearPoint Neuro has 28.27M shares outstanding. The number of shares has increased by 0.77% in one year.

Shares Outstanding 28.27M
Shares Change (YoY) 0.77%
Shares Change (QoQ) 0.17%
Owned by Institutions (%) 27.56%
Shares Floating n/a
Failed to Deliver (FTD) Shares 897
FTD / Avg. Volume 0.35%

Short Selling Information

The latest short interest is 1.21M, so 4.28% of the outstanding shares have been sold short.

Short Interest 1.21M
Short % of Shares Out 4.28%
Short % of Float 4.43%
Short Ratio (days to cover) 3.63

Valuation Ratios

The PE ratio is -21.98 and the forward PE ratio is -17.87. ClearPoint Neuro's PEG ratio is 0.99.

PE Ratio -21.98
Forward PE -17.87
PS Ratio 13.24
Forward PS 4.8
PB Ratio 16.37
P/FCF Ratio -45.06
PEG Ratio 0.99
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ClearPoint Neuro.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.14.

Current Ratio 3.22
Quick Ratio 2.56
Debt / Equity 0.14
Debt / EBITDA -0.2
Debt / FCF -0.39
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $272,956.52
Profits Per Employee $-164,469.57
Employee Count 115
Asset Turnover 0.8
Inventory Turnover 1.79

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 126.3% in the last 52 weeks. The beta is 0.94, so ClearPoint Neuro's price volatility has been higher than the market average.

Beta 0.94
52-Week Price Change 126.3%
50-Day Moving Average 12.75
200-Day Moving Average 13.52
Relative Strength Index (RSI) 49.36
Average Volume (20 Days) 258,834

Income Statement

In the last 12 months, ClearPoint Neuro had revenue of 31.39M and earned -18.91M in profits. Earnings per share was -0.7.

Revenue 31.39M
Gross Profit 19.12M
Operating Income -19.75M
Net Income -18.91M
EBITDA -17.84M
EBIT -19.75M
Earnings Per Share (EPS) -0.7
Full Income Statement

Balance Sheet

The company has 20.1M in cash and 3.57M in debt, giving a net cash position of 16.54M.

Cash & Cash Equivalents 20.1M
Total Debt 3.57M
Net Cash 16.54M
Retained Earnings -191.37M
Total Assets 30.07M
Working Capital 17.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.95M and capital expenditures -275K, giving a free cash flow of -9.22M.

Operating Cash Flow -8.95M
Capital Expenditures -275K
Free Cash Flow -9.22M
FCF Per Share -0.34
Full Cash Flow Statement

Margins

Gross margin is 60.92%, with operating and profit margins of -62.91% and -60.25%.

Gross Margin 60.92%
Operating Margin -62.91%
Pretax Margin -60.25%
Profit Margin -60.25%
EBITDA Margin -56.84%
EBIT Margin -62.91%
FCF Margin -29.39%

Dividends & Yields

CLPT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CLPT is $25, which is 97.6% higher than the current price. The consensus rating is "Strong Buy".

Price Target $25
Price Target Difference 97.6%
Analyst Consensus Strong Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Jul 27, 2016. It was a backward split with a ratio of 1:40.

Last Split Date Jul 27, 2016
Split Type backward
Split Ratio 1:40

Scores

Altman Z-Score 10.53
Piotroski F-Score 4